Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Heart Scan May Be Lifesaver for Diabetics

By HospiMedica staff writers
Posted on 04 Sep 2000
Researchers have found that a fast heart scan using electron beam computed tomography (EBCT) can identify type 1 diabetic patients at high risk for heart disease. More...
Early identification is important, since type 1 diabetics develop heart disease at more than five times the rate of the general population, making it the leading cause of death among these patients. The study, published in the September issue of Diabetes, was conducted by researchers at the University of Pittsburgh Graduate School of Public Health (GSPH) and the University of Pittsburgh Medical Center (UPMC, PA, USA). The study used data from the Pittsburgh Epidemiology of Diabetes Complications Study, an ongoing 10-year prospective study of risk factors for complications of type 1 diabetes.

The EBCT scan measures calcium buildup in the arteries leading to the heart. This buildup is a sign that blockages are developing in the coronary arteries, which may eventually lead to angina and a heart attack. More than 300 participants, all diagnosed as diabetics as children, had the EBCT scan. The researchers then compared their resulting calcium scores with other risk factors and their history of heart disease.

Because patients with Type 1 diabetes might develop extra calcium in their arteries that is not related to atherosclerosis, we were uncertain how well the test would identify subclinical heart disease in these patients, said lead author Jon Olson, Ph.D., of the GSPH. However, we found a strong association between high calcium scores and heart disease, and also between high calcium scores and the standard risk factors.

The researchers say this is the first study to report the use of EBCT to identify diabetics at high risk of heart disease. They plant to continue monitoring the study participants for further signs of heart disease, to determine if the EBCT predicts better than the standard risk factors.

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.